Profile
Full Name
Galmed Pharmaceuticals Ltd.Ticker Symbol
GLMDExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
IsraelIPO
March 13, 2014Indexes
Not includedWebsite
http://www.galmedpharma.comEmployees
3Key Details
Price
$1.32(+4.76%)
Market cap
$2.98M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$8.08(+73.07% YoY)
PE ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Galmed Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 4, 25 Maxim Group
HoldJul 24, 23 Maxim Group
BuyAug 8, 22 Maxim Group
HoldAug 8, 22 Canaccord Genuity
HoldMay 18, 22 Raymond James
Market PerformMay 3, 22 Raymond James
OutperformMay 3, 22 HC Wainwright & Co.
NeutralMay 17, 21 Canaccord Genuity
BuyMar 19, 21 HC Wainwright & Co.
BuyJan 8, 21 Raymond James
OutperformInstitutional Ownership
- What is the ticker symbol for Galmed Pharmaceuticals?
- Does Galmed Pharmaceuticals pay dividends?
- What sector is Galmed Pharmaceuticals in?
- What industry is Galmed Pharmaceuticals in?
- What country is Galmed Pharmaceuticals based in?
- When did Galmed Pharmaceuticals go public?
- Is Galmed Pharmaceuticals in the S&P 500?
- Is Galmed Pharmaceuticals in the NASDAQ 100?
- Is Galmed Pharmaceuticals in the Dow Jones?
- When was Galmed Pharmaceuticals's last earnings report?
- When does Galmed Pharmaceuticals report earnings?
- Should I buy Galmed Pharmaceuticals stock now?
What is the ticker symbol for Galmed Pharmaceuticals?
The ticker symbol for Galmed Pharmaceuticals is NASDAQ:GLMD
Does Galmed Pharmaceuticals pay dividends?
No, Galmed Pharmaceuticals does not pay dividends
What sector is Galmed Pharmaceuticals in?
Galmed Pharmaceuticals is in the Healthcare sector
What industry is Galmed Pharmaceuticals in?
Galmed Pharmaceuticals is in the Biotechnology industry
What country is Galmed Pharmaceuticals based in?
Galmed Pharmaceuticals is headquartered in Israel
When did Galmed Pharmaceuticals go public?
Galmed Pharmaceuticals's initial public offering (IPO) was on March 13, 2014
Is Galmed Pharmaceuticals in the S&P 500?
No, Galmed Pharmaceuticals is not included in the S&P 500 index
Is Galmed Pharmaceuticals in the NASDAQ 100?
No, Galmed Pharmaceuticals is not included in the NASDAQ 100 index
Is Galmed Pharmaceuticals in the Dow Jones?
No, Galmed Pharmaceuticals is not included in the Dow Jones index
When was Galmed Pharmaceuticals's last earnings report?
Galmed Pharmaceuticals's most recent earnings report was on Nov 14, 2024
When does Galmed Pharmaceuticals report earnings?
The next expected earnings date for Galmed Pharmaceuticals is May 30, 2025
Should I buy Galmed Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions